Spire Healthcare upgraded to ‘overweight’ by JP Morgan due to pent-up demand
The private hospital operator is well-placed to deliver capacity, according to analysts
Company
LON:SPI
Spire Healthcare is a leading provider of private healthcare, with 39* private hospitals and 13 clinics across England, Wales and Scotland. The company is built on a proud heritage of over 25 years experience of running successful private hospitals.
79 stories · page 2 of 4
The private hospital operator is well-placed to deliver capacity, according to analysts
Trading is forecast to return to 2019 levels in 2021
Spire will continue providing NHS elective care to reduce waiting lists but it will increase private activity in its 35 English hospitals
Analysts said the massively increased waiting lists are likely to provide better long-term revenue visibility than ever
Spire will be paid enough to cover costs for its services, including operating costs, overheads, use of assets, rent and interest
Private hospital staff and facilities will be “flexibly available to you for urgent surgery, as well as for repurposing their beds, operating theatres and recovery facilities to provide respiratory support for Covid-19 patients,” NHS boss S
Archive
A look at some of the major movers on Friday the 13th
Spire owns 39 hospitals and eight clinics across England, Wales and Scotland
The group slashed its capital investments by 41% in the six months, while targeted marketing campaigns had lifted revenues from private medical insurance
According to UBS research, the NHS’s offering is “generally of high quality”, while dissatisfaction over wait times has stabilised and the public believe healthcare should be government-funded
There was no repeat of the profit warnings seen last year, with Spire confirming it has made a solid start to the year and remains on track to meet full-year expectations
Full-year results are due out next month, and Mediclinic expects underlying earnings to fall by 3.5%, although analysts had thought they might tumble by as much as 4.8%
The Swiss Bank's analysts cut Spire's earnings per share estimates for 2018-2020 by 14-33%, while expecting the group to downgrade its underlying earnings (EBITDA) target for 2022
The broker said that after targeting £200mln+ in underlying earnings (EBITDA) by 2022, it was becoming “increasingly clear” that the targets and timelines were "likely to slip”
Britain’s second-largest healthcare firm said a “prolonged decline” in NHS volumes eroded margins in the first half as it chopped its forecasts for the year
The UK pound is off 0.14% against the US dollar, and flat against the Euro at the time of writing
Archive
Aside the Ocado update, trading news will also arrive from vehicle hire form Northgate, and FTSE 250-listed Spire Healthcare
The FTSE 250-listed firm reported a steep fall in first-half underlying earnings (EBITDA) to £66mln from £83.4mln in 2017 on annual revenue 1.1% lower at £475mln
Mediclinic’s bid for the outstanding 70% of Spire was rejected by the UK healthcare group